MetLife Q3 FY2026 results
$102.65+0.77%
MetLife reported revenue of $20.5 billion, up 18.2% from a year earlier, net income of $2.40 billion and diluted earnings per share of $3.67 against $1.22 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).
From its quarterly report, the results first announced on 4 Nov 2026. Compiled and checked by AapWire.
Q3 FY2026 against Q3 FY2025
Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.
| Measure | Q3 FY2026 | Q3 FY2025 | Change |
|---|---|---|---|
| Revenue | $20.52B | $17.36B | +18.2% |
| Operating income | $1.83B | $1.65B | +10.7% |
| Operating margin | 8.9% | 9.5% | −0.6 pts |
| Net income | $2.40B | $896.0M | +168% |
| Diluted EPS | $3.67 | $1.22 | +201% |
| Operating cash flow | $2.00B | $3.57B | −43.9% |
| Free cash flow | $2.00B | $3.57B | −43.9% |
Operating KPIs for the quarter
| KPI | Q3 FY2026 | Change on a year |
|---|---|---|
| Asset Type unit-linked investments | 125.0M | down 78.4% |
| Institutional Client asset management fees revenue | $187.0M | up 90.8% |
| Prepaid legal plans revenue | $175.0M | up 9.4% |
| Vision fee for service arrangements revenue | $143.0M | up 6.7% |
| Administrative services-only contracts revenue | $81.0M | up 12.5% |
| Recordkeeping and administrative services revenue | $34.0M | down 5.6% |
| Group Benefits revenue | $6.9B | up 3.3% |
| RIS revenue | $4.4B | up 29.9% |
| Asia revenue | $3.4B | up 10.8% |
| Latin America revenue | $2.4B | up 17.2% |
| EMEA revenue | $905.0M | up 14.1% |
| MIM revenue | $322.0M | up 34.7% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sep 2026 | $20.52B | +18.2% | $3.67 |
| Q2 FY2026 | 30 Jun 2026 | $19.15B | +10.5% | $1.09 |
| Q1 FY2026 | 31 Mar 2026 | $19.07B | +2.7% | $1.74 |
| Q4 FY2025 | 31 Dec 2025 | $23.81B | +27.6% | $1.17 |
| Q3 FY2025 | 30 Sep 2025 | $17.36B | −5.9% | $1.22 |
| Q2 FY2025 | 30 Jun 2025 | $17.34B | −2.7% | $1.03 |
| Q1 FY2025 | 31 Mar 2025 | $18.57B | +15.6% | $1.28 |
| Q4 FY2024 | 31 Dec 2024 | $18.67B | −1.9% | $1.78 |
More on MetLife: financial statements · revenue · earnings per share
MET's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.
